4,026 reports of this reaction
1.8% of all HYDROCORTISONE CONTINUOUS SPRAY reports
#11 most reported adverse reaction
DYSPNOEA is the #11 most commonly reported adverse reaction for HYDROCORTISONE CONTINUOUS SPRAY, manufactured by A2A Integrated Pharmaceuticals, LLC. There are 4,026 FDA adverse event reports linking HYDROCORTISONE CONTINUOUS SPRAY to DYSPNOEA. This represents approximately 1.8% of all 229,196 adverse event reports for this drug.
Patients taking HYDROCORTISONE CONTINUOUS SPRAY who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for HYDROCORTISONE CONTINUOUS SPRAY, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for HYDROCORTISONE CONTINUOUS SPRAY:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 4,026 FDA reports for HYDROCORTISONE CONTINUOUS SPRAY. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 1.8% of all adverse event reports for HYDROCORTISONE CONTINUOUS SPRAY, making it a notable side effect.
If you experience dyspnoea while taking HYDROCORTISONE CONTINUOUS SPRAY, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.